Primary Record
Zipalertinib
- In stock
- 6,239 g
- Purity
- 98.2 %
- CAS
- 1661854-97-2
Compound Identifiers & Properties
- CAS
- 1661854-97-2
- PubChem CID
- 117918742
- SMILES
- CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C
- Canonical SMILES
- C=CC(=O)N[C@H]1C=C(C)c2c(-c3cnc4ccccc4c3)c3c(N)ncnc3n2C1
Names & Synonyms
- Zipalertinib
- TAS6417
- 1661854-97-2
- zipalertinibum
- CLN-081
- TAS-6417
- Zipalertinib [INN]
- CLN081
- Cln 081
- T4YMU8TW9H
- TPC064
- TPC-064
- Zipalertinib [WHO-DD]
- RefChem:196114
- UNII-T4YMU8TW9H
- TAS 6417 hydrochloride
- ZIPALERTINIB [USAN]
- TAS 6417
- MFCD31715430
- orb1307699
- Zipalertinib (JAN/USAN/INN)
- Pan-EGFR Inhibitor CLN-081
- CHEMBL4650281
- SCHEMBL16525948
- SCHEMBL29367802
- SCHEMBL29508462
- SCHEMBL30274687
- C23H20N6O
- GTPL11889
- TPC 064
- CHEBI:233402
- MKCYPWYURWOKST-INIZCTEOSA-N
- EX-A3391
- (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide
- BDBM50611355
- NSC812926
- s8814
- 1661854-97-2 (free base)
- AKOS040742682
- Mutation-specific EGFR TKI TAS6417
- NSC-812926
- AC-36462
- AS-79368
- BT171643
- DA-78205
- EGFR Mutant-specific Inhibitor CLN-081
- FT166464
- SY318095
- HY-112299
- CS-0044757
- J3.787.127C
- D13062
- D93895
- Pan-mutation-selective EGFR Inhibitor CLN-081
- A937514
- N-[(8S)-4-Amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
- Pan-mutation-selective EGFR Tyrosine Kinase Inhibitor CLN-081
- 2-Propenamide, N-((8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido(5,4-b)indolizin-8-yl)-
- N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8H,9H-pyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
- (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido(5,4-b)indolizin-8-yl)acrylamide
- (S)-N-[4-Amino-6-methyl-5-(3-quinolyl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]acrylamide
- 2-Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]-
- N-[(5P,8S,10R)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
- N-[(8S)-4-amino-6-methyl-5-(3-quinolyl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
- N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
- Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]- (ACI)